Dr. Selamet is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
725 Albany Street Suite 7a
Shapiro Bldg
Boston, MA 02118Phone+1 617-414-8680Fax+1 617-414-8664
Summary
- I am a board certified nephrologist with extra training in onco-nephrology.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Onco-nephrology, 2016 - 2017
- University of California (San Diego) Medical CenterFellowship, Nephrology, 2013 - 2016
- Quinnipiac University Frank H. Netter MD School of Medicine/St Vincent's Medical CenterResidency, Internal Medicine, 2007 - 2010
- Istanbul University FomClass of 2000
Certifications & Licensure
- MA State Medical License 2019 - 2026
- TX State Medical License 2016 - 2022
- CA State Medical License 2013 - 2021
- RI State Medical License 2010 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
- UC San DiegoCREST (Clinical Research Enhancement through Supplemental Training)
Awards, Honors, & Recognition
- FASN ASN
Publications & Presentations
PubMed
- 185 citationsNephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experienceOmar Mamlouk, Umut Selamet, Shana Machado, Maen Abdelrahim, William F Glass
Journal for Immunotherapy of Cancer. 2019-01-06 - 25 citationsInfliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritis.Jamie S. Lin, Omar Mamlouk, Umut Selamet, Amanda Tchakarov, William F. Glass
Oncoimmunology. 2021-02-02 - 33 citationsCheckpoint inhibitor-related renal vasculitis and use of rituximabOmar Mamlouk, Jamie S. Lin, Maen Abdelrahim, Amanda Tchakarov, William F Glass
Journal for Immunotherapy of Cancer. 2020-07-01
Journal Articles
- Left Ventricular Assist Device (LVAD) patient maintained on home hemo-dialysis.1) Hanna RM, Cruz D, Selamet U, Hasnain H, Kwon M, Baas A, Wilson, J., Hemodialysis International
- Onco-Nephrology Highlights: Chronic kidney disease as a complication of cancerUmut Selamet, Ala Abudayyeh, J Onco-Nephrol, 1/1/2017
Abstracts/Posters
- Nephrotoxicity of Immune Checkpoint Inhibitors: MD Anderson Cancer Center's ExperienceUmut Selamet, Ali Ziaolhagh, Laila S. Lakhani, Amit Lahoti, Biruh Workeneh, Amanda Tchakarov, William F. Glass, Ala Abudayyeh, American Society of Nephrology Meeting, New Orleans, LA, 1/1/2017
- Association of Kidney Function Decline with Survival in Primary MyelofibrosisUmut Selamet, Shouhao Zhou, Juhee Song, Srdan Verstovsek, Ala Abudayyeh, American Society of Nephrology Meeting, New Orleans, LA, 1/1/2017
- Renal biopsy results from patients with Multiple Myeloma-data from a Comprehensive National Cancer Institute: A 10 year MD Anderson ExperienceLaila S. Lakhani, Umut Selamet, Ali Ziaolhagh, William F. Glass, Amanda Tchakarov, Ala Abudayyeh, American Society of Nephrology Meeting, New Orleans, LA, 1/1/2017
- Join now to see all
Professional Memberships
- Member
Other Languages
- Turkish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: